|
1
|
García de Tena J: Inflammation,
atherosclerosis, and coronary artery disease. N Engl J Med.
353:429–430; author reply 429–430. 2005. View Article : Google Scholar
|
|
2
|
Anderson L, Oldridge N, Thompson DR,
Zwisler AD, Rees K, Martin N and Taylor RS: Exercise-based cardiac
rehabilitation for coronary heart disease: Cochrane systematic
review and meta-analysis. J Am Coll Cardiol. 67:1–12. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Catapano AL, Chapman J, Wiklund O and
Taskinen MR: The new joint EAS/ESC guidelines for the management of
dyslipidaemias. Atherosclerosis. 217:1–44. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lloyd-Jones D, Adams R, Carnethon M, De
Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund
K, et al American Heart Association Statistics Committee and Stroke
Statistics Subcommittee, : Heart disease and stroke statistics -
2009 update: A report from the American Heart Association
Statistics Committee and Stroke Statistics Subcommittee.
Circulation. 119:e21–e181. 2009.PubMed/NCBI
|
|
5
|
Chen BJ, Pan ZQ and Su XX: Study on
changes of TCM syndrome in patients with coronary heart disease
before and after intervention treatment. Zhongguo Zhong Xi Yi Jie
He Za Zhi. 27:689–691. 2007.(In Chinese). PubMed/NCBI
|
|
6
|
Pogosova N, Kotseva K, De Bacquer D, von
Känel R, De Smedt D, Bruthans J and Dolzhenko M: EUROASPIRE
Investigators: Psychosocial risk factors in relation to other
cardiovascular risk factors in coronary heart disease: Results from
the EUROASPIRE IV survey. A registry from the European Society of
Cardiology. Eur J Prev Cardiol. 24:1371–1380. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mackay LK, Rahimpour A, Ma JZ, Collins N,
Stock AT, Hafon ML, Vega-Ramos J, Lauzurica P, Mueller SN,
Stefanovic T, et al: The developmental pathway for
CD103+CD8+ tissue-resident memory T cells of
skin. Nat Immunol. 14:1294–1301. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Marsolais D, Yagi S and Rosen H:
Activation of sphingosine-1-phosphate receptor 1 inhibits
CD4+ T cell response in a murine model of allergic
airway inflammation. Am J Respir Crit Care Med. 179:A43042009.
|
|
9
|
Kumar SS, Tomita Y, Wrin J, Bruhn M,
Swalling A, Mohammed M, Price TJ and Hardingham JE: High early
growth response 1 (EGR1) expression correlates with resistance to
anti-EGFR treatment in vitro and with poorer outcome in metastatic
colorectal cancer patients treated with cetuximab. Clin Transl
Oncol. 19:718–726. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bhattacharyya S, Wu M, Fang F,
Tourtellotte W, Feghali-Bostwick C and Varga J: Early growth
response transcription factors: Key mediators of fibrosis and novel
targets for anti-fibrotic therapy. Matrix Biol. 30:235–242. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun M, Nie FQ, Zang C, Wang Y, Hou J, Wei
C, Li W, He X and Lu KH: The pseudogene DUXAP8 promotes
non-small-cell lung cancer cell proliferation and invasion by
epigenetically silencing EGR1 and RHOB. Mol Ther. 25:739–751. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dang Y, Luo D and Rong M: Underexpression
of miR-34a in hepatocellular carcinoma and its contribution towards
enhancement of proliferating inhibitory effects of agents targeting
c-MET. PloS one. 8:e610542013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Satija A, Bhupathiraju SN, Spiegelman D,
Chiuve SE, Manson JE, Willett W, Rexrode KM, Rimm EB and Hu FB:
Healthful and unhealthful plant-based diets and the risk of
coronary heart disease in U.S. adults. J Am Coll Cardiol.
70:411–422. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Blechacz B: Cholangiocarcinoma: Current
knowledge and new developments. Gut Liver. 11:13–26. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou M, Wang H, Zhu J, Chen W, Wang L, Liu
S, Li Y, Wang L, Liu Y, Yin P, et al: Cause-specific mortality for
240 causes in China during 1990–2013: A systematic subnational
analysis for the Global Burden of Disease Study 2013. Lancet.
387:251–272. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Danad I, Szymonifka J, Twisk JWR, Norgaard
BL, Zarins CK, Knaapen P and Min JK: Diagnostic performance of
cardiac imaging methods to diagnose ischaemia-causing coronary
artery disease when directly compared with fractional flow reserve
as a reference standard: A meta-analysis. Eur Heart J. 38:991–998.
2017.PubMed/NCBI
|
|
17
|
Kimura MY, Hayashizaki K, Tokoyoda K,
Takamura S, Motohashi S and Nakayama T: Crucial role for CD69 in
allergic inflammatory responses: CD69-Myl9 system in the
pathogenesis of airway inflammation. Immunol Rev. 278:87–100. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hayashi Y, Okutani M, Ogawa S, Tsukahara T
and Inoue R: Generation of anti-porcine CD69 monoclonal antibodies
and their usefulness to evaluate early activation of cellular
immunity by flow cytometric analysis. Anim Sci J 2018. Anim Sci J.
89:825–832. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lei L, Cui L, Mao Y, Zhang X, Jiang Q,
Dong S and Wang Y: Augmented CD25 and CD69 expression on
circulating CD8+ T cells in type 2 diabetes mellitus
with albuminuria. Diabetes Metab. 43:382–384. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ghatak S, Markwald RR, Hascall VC, Dowling
W, Lottes RG, Baatz JE, Beeson G, Beeson CC, Perrella MA,
Thannickal VJ, et al: Transforming growth factor β1 (TGFβ1)
regulates CD44V6 expression and activity through extracellular
signal-regulated kinase (ERK)-induced EGR1 in pulmonary fibrogenic
fibroblasts. J Biol Chem. 292:10465–10489. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shajahan-Haq AN, Boca SM, Jin L,
Bhuvaneshwar K, Gusev Y, Cheema AK, Demas DD, Raghavan KS, Michalek
R, Madhavan S, et al: EGR1 regulates cellular metabolism and
survival in endocrine resistant breast cancer. Oncotarget.
8:96865–96884. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu S, Bendeck M and Gotlieb AI: Vascular
pathobiology: Atherosclerosis and large vessel disease.
Cardiovascular Pathology. Butany J and Buja M: 4th. Academic Press;
MA: pp. 85–124. 2016, View Article : Google Scholar
|
|
23
|
Toutouzas K, Colombo A and Stefanadis C:
Inflammation and restenosis after percutaneous coronary
interventions. Europ Heart J. 25:1679–1687. 2004. View Article : Google Scholar
|
|
24
|
Vogt A: Hyperlipoproteinaemia(a) -
apheresis and emerging therapies. Clin Res Cardiol Suppl. 12 Suppl
1:12–17. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tayefi M, Tajfard M, Saffar S, Hanachi P,
Amirabadizadeh AR, Esmaeily H, Taghipour A, Ferns GA, Moohebati M
and Ghayour-Mobarhan M: hs-CRP is strongly associated with coronary
heart disease (CHD): A data mining approach using decision tree
algorithm. Comput Methods Programs Biomed. 141:105–109. 2017.
View Article : Google Scholar : PubMed/NCBI
|
